I. Jabin Group

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | All articles |


"The incorporation of calix[6]arene and cyclodextrin derivatives into sol-gels for the preparation of stationary phases for gas chromatography"

Delahousse, G.; Peulon-Agasse, V.; Debray, J.-C.; Vaccaro, M.; Cravotto, G.; Jabin, I.; Cardinael P. J. Chromatogr. A, 2013, 1318, 207-216.icon
 

"Selective Extraction and Efficient Binding in a Protic Solvent of Contact Ion-Triplets Using a Thiourea Based Bis-Calix[6]arene Receptor"

Moerkerke, S.; Le Gac, S.; Topić, F.; Rissanen, K.; Jabin I. Eur. J. Org. Chem. 2013, 5315-5322.icon
 

calix[6]arene including ion-triplet

"Synthesis, electrochemical and photophysical properties of calixarene based Ru(II) complexes as potential multivalent photoreagents"

Mattiuzzi, A.; Marcélis, L.; Jabin, I.; Moucheron, C.; Kirsch-De Mesmaeker, A. Inorg. Chem. 2013, 52, 11228-11236.icon
 

TOC20calix20Ru3

"Efficient “one-pot” methodology for the synthesis of novel tetrahydro-β-carboline, tetrahydroisoquinoline and tetrahydrothienopyridine derivatives"

Ionescu, A.; Cornut, D.; Soriano, S.; Guissart, C.; Van Antwerpen, P.; Jabin, I. Tetrahedron Lett. 2013, 54, 6087-6089.icon
 

"Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity" 

Lallemand, B.; Ouedraogo, M.; Wauthoz, N.; Lamkami, T.; Mathieu, V.; Jabin, I.; Amighi, K.; Kiss, R.; Dubois, J.; Goole, J. J. Pharm. Pharmacol., 2013, 65, 402-410.icon

 

"Construction de surfaces modifiées par une monocouche de calix[4]arènes : contrôle chimique et spatial à l’échelle moléculaire" 

Mattiuzzi, A.; Jabin, I.; Reinaud, O.; Hapiot, P.; Lagrost, C. Chimie Nouvelle 2013, 114, 11-15.icon